• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY PROMUS PREMIER?; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY PROMUS PREMIER?; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number H7493952812350
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Apnea (1720); Cardiac Arrest (1762); Death (1802); Dyspnea (1816); Myocardial Infarction (1969); Ventricular Fibrillation (2130); Loss of consciousness (2418); Loss Of Pulse (2562)
Event Date 05/31/2015
Event Type  Death  
Event Description
(b)(4) clinical study.It was reported that myocardial infarction and cardiac arrest occurred.In (b)(6) 2015, clinical assessment indicated that the patient's qualifying condition was stable angina.Subsequently, index procedure was performed.The target lesion was a de novo lesion located in the mid left anterior descending(lad) to the proximal lad with 60% stenosis and was 28 mm long with a reference vessel diameter of 2.5 mm.The lesion was treated with pre-dilatation and placement of a 3.5x12mm promus premier¿ stent.Following post dilation, residual stenosis was 0%.One day post procedure, the patient was discharged on aspirin and clopidogrel.Ten days post procedure, the patient complained of shortness of breath and not feeling well.The patient was taken to the emergency room and it was then noted that the patient was unresponsive, apneic, and pulseless.The patient was intubated on arrival and resuscitation was started.Under examination, the patient was found to have a distended abdomen, pale, flushed skin, cool to the touch and a thready pulse.An automatic implantable cardiac defibrillator was present on the left side.The patient was shocked several times, but remained in ventricular fibrillation, despite resuscitation efforts.On that same day, the patient died of cardiac arrest secondary to complications of coronary artery disease.
 
Manufacturer Narrative
(b)(4).Device is a combination product.Device evaluated by mfr: the complaint device was not returned for analysis.The manufacturing batch record review confirmed that the device met all material, assembly and performance specifications.The most probable root cause was unable to be determined.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS PREMIER?
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
Manufacturer (Section G)
BOSTON SCIENTIFIC - GALWAY
Manufacturer Contact
linda leimer
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key4954140
MDR Text Key6635509
Report Number2134265-2015-05014
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P110010
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 07/02/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/30/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date04/30/2016
Device Model NumberH7493952812350
Device Catalogue Number39528-1235
Device Lot Number17523418
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/02/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/22/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death; Required Intervention;
Patient Age71 YR
-
-